Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.
Interesting Engineering - First Ever HIV Immunotherapy Drug Proven Safe For Use in Humans
Latest News
Alison Hall, PhD, senior associate dean for research at the GW School of Medicine and Health Sciences (SMHS), recently assumed the added role of interim director of the GW Cancer Center following the departure of Julie Bauman, MD. In this Q+A she discusses future plans for the GW Cancer Center.
Abigail Polter, PhD, associate professor of pharmacology and physiology, recently received a grant from the Aligning Science Across Parkinson’s (ASAP) initiative to study a small, but integral part of the mid-brain, called the ventral tegmental area responsible for executive function that she…
Pedro Gazzinelli Guimarães, PhD, assistant professor of microbiology, immunology, and tropical medicine, was recently named among the “New Voices in Microbiology” by the journal Infection and Immunity.
